parasympathetic and sympathetic nervous system Flashcards
(44 cards)
M1 , M2, M3: where do they work?
- side effects
- M 1 ,M 3 stomach and glands, bronchial smooth
muscle, eye ciliary muscle excitation –, vascular
endothelium (NO) inhibition - M 2 heart inhibition
- Side effects: bradycardia bronchoconstrictio miosis salivation vomiting, diaorrhea urination
Muscarinic ACh receptors:
- response to ACh binding =
G protein cascade is activated
Indirect parasympathomimetics
- how they work
ACh esterase enzyme inhibition —> ACh
degradation is reduced
Carbachol
non specific to M ACh receptors: several side effects
excellent activity, nowadays: exclusively locally
1. applied in the uterus in the case of metritis (intrauterine)
- Bethanechol
2. Methacholine
used in human medicine mostly
- M- ACh specific
induction of intestinal peristalsis after operations
urinary bladder atony ! (veterinary field)
M ACh specific
cardiovascular system —> atrial fibrillation
pronounced peripherial vasodilatation —> ergot toxicosis
Pilocarpine
- use
- side effects
natural alkaloid ( Pilocarpus jaborandi)
earlier: important role in ophtalmology
1. GLAUCOMA therapy (miosis can be seen after approx. 15 mins)
2. KCS (Keratoconjunctivitis sicca): effect is ambiguous
side effect: mild after local administration
Direct parasympathomimetics
Acetylcholine (ACh) Carbachol Bethanechol Methacholine Pilocarpine
Receptors for indirect parasympathomimetics:
primarily on nicotinic ACh receptors
furthermore on muscarinic ACh receptors
on ACh receptors in the CNS
Physostigmine
- characteristics
- use
- contains tertiary nitrogen –> lipophilic –> kinetics!
- very small therapeutic index systemically (atropine poisoning)
- eye drop : glaucoma treatment
Neostigmine
- Characteristics
- use
•quaternary nitrogen —> less lipophilic –> kinetics!
•eye drop : treatment of glaucoma
•given systemically it is safer
- Given IV or IM
- myasthenia gravis treatment
suspending the action of non depolarizing muscle relaxants - increasing intestinal motility
- inducing emesis
Pyridostigmine
- Characteristics
- admin
- use
- quaternary nitrogen –> less lipophilic –> kinetics!
•given systemically it is safer
•orally this has the best bioavailability (F=3 8% only)
Use:
myasthenia gravis treatment
increasing intestinal motility
Edrophonium
- Characteristics
- effect, use
•competitive inhibition in the neuromuscular junction —> action is suspended by diffusion
•short effect: 5-15 minutes
- myasthenia gravis diagnosis = Tensilon test
Organophosphates
- Characteristics
- use
- antidote
- irreversible
- inhibitors of AChE
- ectoparasiticides (e.g. diazinon)
- in humans treatment of glaucoma (e.g. echothiophate)
antidote: atropine, pralidoxime
Indirect parasympathomimetics
Organophosphates Edrophonium Pyridostigmine Neostigmine Physostigmine
Atropine
Dose (mg/kg) Symptoms
Dose (mg/kg) Symptoms
0,5 :Mouth dryness, decreased perspiration
1: tachycardia, mydriasis
2: +accomodation, disturbances
5: +constipation
10: +ataxia, excitation, hallucination, delirium, coma
Drugs used in:
- diagnostic examination of the eye
- in uveitis the prevention of synechiae
- tropicamide,homatropine (short acting)
2. atropine (long acting)
atropine was used earlier for
premedication which drug is most used now?
glycopyrrolate
Drug used in treatment of horse RAO, COPD and human
(feline) asthma :
ipratropium
decreases secretion and motility (used
in ruminants)
benzethimide
decreases smooth muscle function –> antispasmodic
effect in the intestine –> very effective in horse colic
esp. butyl scopolamine
Which animal is relatively resistant to atropine! (liver atropinase)
Rabbit
Atropine toxicosis symptoms:
Symptoms: dry mouth, tachycardia, mydriasis, constipation, convulsions, coma, death
α1 receptor effects:
smooth muscle contraction
*increased sphincter constriction
vasoconstriction
mydriasis
α2 receptor effects:
inhibition of neurotransmitter release (NA!)
GI relaxation
inhibition of insulin release